Augmedix, Inc. (NASDAQ:AUGX) Q4 2021 Results Conference Call March 21, 2022 4:30 PM ET Company Participants Caroline Paul - IR Manny Krakaris - CEO Paul Ginocchio - CFO Conference Call Participants Jared Haase - William Blair Marc Wiesenberger - B Riley Allen Klee - Maxim Group Brooks O’Neil - Lake Street Capital Markets Operator Greetings. Welcome to the Augmedix, Inc. 2021 Fourth Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of Each Class Trading Symbol Name of Each Exchange on Which Registered None N/A N/A FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission file number: 000-56036 MALO HOLDIN ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission file number: 000-56036 MALO HOLDINGS CORPORATION (Exact name of registrant as specified in its charter) | --- | --- | |---------- ...